These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Novel thieno oxazine analogues as antihyperglycemic and lipid modulating agents. Das SK; Reddy KA; Abbineni C; Iqbal J; Suresh J; Premkumar M; Chakrabarti R Bioorg Med Chem Lett; 2003 Feb; 13(3):399-403. PubMed ID: 12565938 [TBL] [Abstract][Full Text] [Related]
12. Antihyperglycemic and antihyperlipidemic effects of newly synthesized glibenclamide analogues on streptozotocin-diabetic rats. Ahmadi A; Khalili M; Farsadrooh M; Ghiasi M; Nahri-Niknafs B Drug Res (Stuttg); 2013 Dec; 63(12):614-9. PubMed ID: 23828271 [TBL] [Abstract][Full Text] [Related]
14. Evidence of hypoglycemic, lipid-lowering and hepatoprotective effects of the Bixin and Bixin: β-CD inclusion compound in high-fat-fed obese mice. Pinzón-García AD; Orellano LAA; de Lazari MGT; Campos PP; Cortes ME; Sinisterra RD Biomed Pharmacother; 2018 Oct; 106():363-372. PubMed ID: 29966982 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: a novel series of PPAR gamma agonists. Azukizawa S; Kasai M; Takahashi K; Miike T; Kunishiro K; Kanda M; Mukai C; Shirahase H Chem Pharm Bull (Tokyo); 2008 Mar; 56(3):335-45. PubMed ID: 18310946 [TBL] [Abstract][Full Text] [Related]
16. Sensitization to insulin induced by beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in obese Zucker rats in vivo. Mayorek N; Kalderon B; Itach E; Bar-Tana J Diabetes; 1997 Dec; 46(12):1958-64. PubMed ID: 9392480 [TBL] [Abstract][Full Text] [Related]
18. Examination of the structural requirements for proliferation of peroxisomes and mitochondria in mouse liver by hypolipidemic agents, with special emphasis on structural analogues of 2-ethylhexanoic acid. Lundgren B; Meijer J; DePierre JW Eur J Biochem; 1987 Mar; 163(2):423-31. PubMed ID: 3028804 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, hypoglycaemic, hypolipidemic and PPARγ agonist activities of 5-(2-Alkyl/aryl-6-Arylimidazo[2,1-b][1,3,4]thiadiazol-5-yl)methylene-1,3-thiazolidinediones. Khazi MI; Belavagi NS; Kim KR; Gong YD; Khazi IA Chem Biol Drug Des; 2013 Aug; 82(2):147-55. PubMed ID: 23581650 [TBL] [Abstract][Full Text] [Related]
20. Hypolipidemic activity of phthalimide derivatives IV: Further chemical modification and investigation of the hypolipidemic activity of N-substituted imides. Chapman JM; Cocolas GH; Hall IH J Pharm Sci; 1983 Nov; 72(11):1344-7. PubMed ID: 6644601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]